Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Luna Fit
MyDrHank review
A flat, all-dose price on both molecules — including the tirzepatide most insulin-resistance readers are actually here for — from a general telehealth shop that publishes its ladder openly but shows you only the twelve-month rung of it.
- Semaglutide
- $259/mo month-to-month (from $178/mo on a 12-month prepay, $2,140 up front) — the site displays only the prepay rate
- Tirzepatide
- $349/mo month-to-month (from $240/mo on a 12-month prepay, $2,883 up front) — the site displays only the prepay rate
- Coverage
- No state list published; its affiliate terms exclude Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia
- Brand-name
- Compounded only
The Luna Fit scorecard
MyDrHank scored on our six women's-health factors. See the methodology.
What we like
- Tirzepatide is a first-class option here, not an upsell — the dual GIP/GLP-1 agonist is the one most readers arriving on insulin-resistance questions ask about by name
- The price does not move with the dose: its GLP-1 FAQ states "the price stays the same at every dose — no surprise price increases", so a titration to a higher dose does not re-price the plan
- Prices are published before any intake quiz — the full four-rung ladder for every product, with the up-front total beside each per-month figure, rather than a number you have to qualify for
- An oral semaglutide tablet at $249/mo month-to-month sits alongside the injectables, so needle aversion does not mean changing provider
- A LegitScript seal carrying a published ID (3314240) links out to LegitScript's own verifier, rather than sitting on the page as a flat badge image
- A U.S. board-certified clinician reviews every intake, with a stated 24-hour turnaround
The caveats
- Every price the site displays is the TWELVE-MONTH PREPAY rate — the renderer takes the cheapest rung of the ladder — so the month-to-month figures ($349 tirzepatide, $259 semaglutide) are shown on no page at all
- Its own footnote advertises a tirzepatide price that exists at no tier: "Plans start at $171/mo for compounded semaglutide and $200/mo for compounded tirzepatide" — $200 appears exactly once in the entire site bundle and no tirzepatide rung costs it; the $171 in the same sentence is the ORAL product's yearly rate, while injectable semaglutide's is $178
- The GLP-1 FAQ calls a prepaid annual rate a plan with "no contract", which is true of the paperwork and misleading about the money
- Compounded semaglutide and tirzepatide are not FDA-approved, and no brand-name Wegovy, Zepbound, Ozempic or Mounjaro route exists here at all
- No labs and no bloodwork are required to start, and no monitoring cadence is published — thin oversight if thyroid, androgens or hormonal markers are part of your picture
- No served-states list is published anywhere on the consumer site; the six excluded states are known only from its affiliate terms
- A general shop rather than a hormonal one — there is no PCOS, perimenopause or menopause program, and the same account sells ED, hair-loss and sexual-health lines
The bottom line
Best for: Readers treating insulin resistance who want tirzepatide at a price that does not climb with the dose, and who will open the plan selector and pay the month-to-month rate rather than the advertised one. A flat, all-dose price on both molecules — including the tirzepatide most insulin-resistance readers are actually here for — from a general telehealth shop that publishes its ladder openly but shows you only the twelve-month rung of it.
Ranked #50 of 80 providers we reviewed for women — see our #1 pick, CoreAge Rx, for comparison. Cancellation fairness is where MyDrHank scores lowest, at 66/100. If that is your sticking point, start with the full field we rank against MyDrHank.
Others in MyDrHank's score range
The providers scoring closest to MyDrHank on the same six factors. One of those comparisons is written out in full: MyDrHank against CoreAge Rx, factor by factor, 20 points apart on the Luna Fit Score. Directly below MyDrHank sits Try Ageless at #51 with 73/100 — see our ranked shortlist of Try Ageless alternatives if that is the band you are shopping in.
See all 80 providers we've reviewed for women — ranked on the same rubric, with scores and pricing side by side.
Pricing, states and verification reflect MyDrHank's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on MyDrHank's site. Not medical advice; see our disclosure.